• Print
  • Email
  • Favorite
  • Share
  • Newsletters

Veterinarians have been using an antibody product to treat West Nile virus (WNV) clinical signs, but its use for this purpose is currently off-label (not approved by the USDA). Currently, the hyperimmune plasma product HiGamm-Equi, by Lake Immunogenics, is being examined by the USDA for conditional approval.

HiGamm-Equi is typically used for failure of passive transfer in foals--the

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners